Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INFLIXIMAB-DYYB Cause Therapy interrupted? 254 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 254 reports of Therapy interrupted have been filed in association with INFLIXIMAB-DYYB (ZYMFENTRA). This represents 1.0% of all adverse event reports for INFLIXIMAB-DYYB.

254
Reports of Therapy interrupted with INFLIXIMAB-DYYB
1.0%
of all INFLIXIMAB-DYYB reports
1
Deaths
28
Hospitalizations

How Dangerous Is Therapy interrupted From INFLIXIMAB-DYYB?

Of the 254 reports, 1 (0.4%) resulted in death, 28 (11.0%) required hospitalization, and 5 (2.0%) were considered life-threatening.

Is Therapy interrupted Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INFLIXIMAB-DYYB. However, 254 reports have been filed with the FAERS database.

What Other Side Effects Does INFLIXIMAB-DYYB Cause?

Off label use (14,256) Condition aggravated (10,275) Intentional product use issue (7,549) Inappropriate schedule of product administration (5,977) Arthralgia (4,615) Drug ineffective (3,112) Fatigue (3,111) Weight increased (2,848) Malaise (2,766) Weight decreased (2,703)

What Other Drugs Cause Therapy interrupted?

ADALIMUMAB (5,755) ETANERCEPT (3,397) RELUGOLIX (3,251) CERTOLIZUMAB PEGOL (3,209) LENALIDOMIDE (2,724) UPADACITINIB (1,741) ABATACEPT (1,726) CLOZAPINE (1,722) AMIKACIN (1,283) TOFACITINIB (1,182)

Which INFLIXIMAB-DYYB Alternatives Have Lower Therapy interrupted Risk?

INFLIXIMAB-DYYB vs INFLIXIMAB-QBTX INFLIXIMAB-DYYB vs INFLIXIMAB, RECOMBINANT INFLIXIMAB-DYYB vs INFLUENZA A VIRUS A/CALIFORNIA/7/2009 LIVE ANTIGEN\INFLUENZA A VIRUS A/TEXAS/50/2012 LIVE ANTIGEN\INFLUENZA B VIRUS B/BRISBANE/60/2008 LIVE ANTIGEN\INFLUENZA B VIRUS B/MASSACHUSETTS/2/2012 LIVE ANTIGEN INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE INFLIXIMAB-DYYB vs INFLUENZA VIRUS VACCINE QUADRIVALENT TYPE A+B

Related Pages

INFLIXIMAB-DYYB Full Profile All Therapy interrupted Reports All Drugs Causing Therapy interrupted INFLIXIMAB-DYYB Demographics